We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $1.93B
1-Year Est. Return 134.74%
This Fund
S&P 500
This Quarter Est. Return
+46.67%
1 Year Est. Return
+134.74%
3 Year Est. Return
+450.5%
5 Year Est. Return
+913.18%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$235M
Cap. Flow
-$90.5M
Cap. Flow %
-8.72%
Top 10 Hldgs %
62.46%
Holding
79
New
20
Increased
8
Reduced
18
Closed
12

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$12.9M
2
NVO
Novo Nordisk
NVO
+$12.2M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.92M
4
HALO icon
Halozyme
HALO
+$6.5M
5
BPMC
Blueprint Medicines
BPMC
+$5.31M

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$43.8M
2
SNY icon
Sanofi
SNY
+$14.2M
3
GILD icon
Gilead Sciences
GILD
+$13.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.3M
5
INCY icon
Incyte
INCY
+$11M

Sector Composition

Rank Sector Weight
1 Healthcare 89.88%
2 Miscellaneous 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIMT
76
DELISTED
Aimmune Therapeutics
AIMT
– –
-175,775
Closed -$4.21M
TSRO
77
DELISTED
TESARO, Inc.
TSRO
– –
-134,297
Closed -$9.97M
1 2 3
4

Similar funds

GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
EK
Evensky & Katz Coral Gables, Florida $1.94B AUM 22.01% 1-Year Est. Return
CTI
Community Trust & Investment Versailles, Kentucky $1.94B AUM 29.99% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
P3I
Progeny 3 Inc Kirkland, Washington $1.94B AUM 19.13% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $1.94B AUM 48.68% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return

Sofinnova Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Sofinnova Investments held 79 positions worth $1.04B, up 29% from $803M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sofinnova Investments withdrew a net $90.5M in Q1 2019, closing 12 positions and reducing 18 holdings. Its most notable exit was Sanofi, an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 95% a quarter earlier, followed by Miscellaneous.

Against the trend, Sofinnova Investments opened a new position in Allergan plc worth $13M.

  • Sofinnova Investments's largest Q1 2019 buy was Allergan plc: 88,665 shares worth $13M.
  • Sofinnova Investments added most to AnaptysBio in Q1 2019, an estimated $5.03M increase.
  • Sofinnova Investments's biggest Q1 2019 reduction was Ascendis Pharma A/S, cutting an estimated $43.8M.
  • Sofinnova Investments fully exited Sanofi in Q1 2019, selling an estimated $14.2M.
  • Sofinnova Investments's ten largest holdings make up 62% of its $1.04B portfolio in Q1 2019.
  • Sofinnova Investments opened 20 new positions and closed 12 in Q1 2019.
  • Sofinnova Investments's portfolio value rose 29% quarter-over-quarter to $1.04B.

Based on Sofinnova Investments's 13F filing for Q1 2019, filed 15 May 2019.